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Although application of tar products and subsequent 
exposure to ultraviolet radiation (the Goeckerman regi-
m en) has repeatedly been demonstrated to be effective 
therapy for psoriasis, the therapeutic role of each com-
ponent has r emained uncertain. Utilizing the bilateral 
compa rison technique in 30 hospitalized patients with 
chronic stable plaque-type psoriasis vulgaris, we closely 
monitored the clinical responses to ultraviolet radiation 
(Westinghouse fluorescent FS40 bulbs, 290-400 nm) and 
a variety of tar preparations and lubricant vehicles in 
combination and separately. We found that: 1) 4 weeks 
of maximally-aggressive exposure to ultraviolet radia-
tion alone will markedly improve, but not completely 
clear, psoriasis unless combined with a tar preparation 
or lubricating base; 2) 5% crude coal tar plus ultraviolet 
radiation offers no clear advantage or benefit over lu-
bricating base plus ultraviolet radiation; and 3) none of 
the tar preparations tested offered any consistent advan-
tage over any other preparation. 
More than 50 yr ago, Goeckerman [1] published his initial 
observation that repeated treatments with topical crude coal 
tar (CCT) and subsequent remova l wit h olive oil followed by 
ultraviolet (UV) irradiation from a medium pressure mercury 
discharge lamp cleared plaques of psoriasis in 3-to-4 weeks. 
Since that t ime, controversy has centered not on the effective-
ness of t his widely accepted therapy, but around the mechanism 
and t he necessary and essential components of the "Goecker-
man regimen." 
While Ellis, Wooldridge and Weiss [2] were able to clear 
psoriatic plaques with tar products (liquor carbonis detergens) 
alone, Petrozzi et al [3] were less satisfi ed with the response to 
CCT alone, although most of their patien ts' psoriasis improved 
50% or more. The direct comparison of these studies and others 
ut ilizing tar products is obfuscated by our inability to charac-
terize fully all components of this substance. Crude coal tar, a 
product of the destructive distillation of bituminous coal, is a 
mixture of approximately 10,000 diffe rent compounds (of which 
approximately 400 are known) including benzene, naphthalene, 
phenols, and pitch [4,5]. The actual composition of CCT may 
vary depending upon the quality of the coal and the manufac-
ture r's distillation process. 
In addition to topical CCT , the Goeckerman regimen requires 
ultraviolet radiation. The source originally used by Goeckerman 
[1) emits broad spectrum ultraviolet radiation. With varying 
degrees of technological sophistication, investigators have 
reached various conclusions concerning the role of UV in the 
Goeckerman regimen therapy of psoriasis: (1) UV plays no role 
[6]; (2) UV alone is less effective than UV plus tar [7]; (3) UVB 
alone (primarily 313 nm) can clear. psoriasis [8); (4) UV A alone 
(320-400 nm) in erythemogenic doses can improve psoriasis 
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vulgaris [9]; (5) using erythemogenic doses, UV A plus tar is as 
effective as tar plus UVB [10); (6) UV A and UVB in a propor-
t ion mimicking summer sunligh t is beneficial [11]; (7) plaques 
of psoriasis respond similarly to UVB or CCT plus UVB [3]; (8) 
tar plus UV is superior to tar alone [12]; and (9) the combined 
use of UV and dithranol achieves better resul ts t ha n when 
either is employed separately [13]. 
In this study, we used the bilateral comparison technique in 
a car efully controlled manner to study in-pat ients who received 
daily aggressive UV exposures which produced barely percep-
tible delayed erythema. With the use of appropriate control 
sites, the bilateral comparison technique allows one to draw 
conclusions with smaller sample populations, because the com -
pa rison of 2 the ra pies in the same person eliminates som e of 
t he vagaries of the disease and because each person serves as 
his own control. We examined the relative importa nce of each 
of the components of the Goeckerman regimen separately a nd 
in combination: the UV, the tar preparation, and the vehicle 
for the CCT. 
MATERIALS AND METHODS 
Thirty (30) patients with chronic, stable, plaque-type psoriasis vul-
garis involving more than 30% (range 30-85%) of their body surface 
were hospitalized for the duration of this study. During the course of 
this study no patient ingested any medication known to affect psoriasis 
or photobiologic responses to UV radiation. No topical medications 
except those specified below were used on any body surface. All patients 
were aware that each side of their body would receive a different topical 
therapy and that consequently one side might clear faster than the 
other. 
Patients were sequentially divided into Group A (15 patients) and 
Group B (15 patients) . Each group was further subdivided into 3 
subgroups consisting of 5 patients. The endpoint for Group A was 3 
weeks of hospitalization and for Group B was 3 days of treatment after 
one side was at least 95% clear of psoriasis. These 3 days allowed 
additional time for the contralateral side to respond. 
Prior to admission each patient's minimal erythema dose (MED) to 
UVB (FS40 flu orescent sunlamps) was determined. Additionally, the 
minimal phototoxic dose (MPD) to UV A (FH40 PUV A fluorescent 
lamps) was determined in order to verify the phototoxicity of the 5% 
CCT used in this study. The MPD was determined by irradiating skin 
previously treated with the topical tar preparation or white petrolatum; 
both MED and MPD were obtained on nonsun-exposed areas. Upon 
admission to the hospita l, each patient received a routine history and 
physical evaluation, was photographed, and was given a copy of the 
applicable protocol which was reviewed with a physician. The protocol 
specified no occlusive wraps, no topical medications except those pre-
scribed by the physician, no moisturizers or lubricants, the use of Keri 
soap, and cotton pajamas specifically designated for the study. 
All patients received daily (7 times weekly) tota l body UV exposure. 
The only exceptions were the control patches and any area that 
remained erythematous 24 hr subsequent to UV exposure. Two pairs 
of bilaterally symmetrical 4 cm x 4 cm sites which included plaques of 
psoriasis were chosen as control sites, and these received no UV 
exposure. One pair of these sites also received no topical applications. 
Patient Groups 
AU patients received UV exposure to their entire body. The bilateral 
comparisons were as follows: 
Group A (Endpoint 3 Weehs of Treatment) 
1) 5% CCT in white petrolatum vs Eucerin. 
2) 5% Liquor carbon is detergens vs Eucerin. 
3) Estar gel (Westwood Pharmaceuticals, Inc.) vs Eucerin. 
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Group B (Endpoint Was Clearance on One Side Plus 3 Days) 
1) White petrolatum vs no topical therapy. 
2) 5% CCT in white petrolatum vs no topical therapy. 
3) 5% CCT in white petrolatum vs white petrolatum. 
The daily routine was as follows: 
1) Awake; remove tal' preparation with mineral oil. 
2) Shower with warm water and soap. 
3) Two hours after shower, receive total-body UV exposure. 
4) After UV exposure, apply the specified topical unguents evenly to 
the entire appropriate side, avoiding the face, all intertriginous areas, 
and contro l sites. Repeat at bedtime. 
Daily, a physician evaluated the clinical response and determined 
the UV dose. The rust UV exposure for each patient was calculated to 
be 80% of his predetermined MED. Subsequent exposure doses were 
calculated using the following schedule: 
1) No erythema present-20% of previous dose + previous dose; 
2) Trace erythema present-repeat previous dose; and 
3) Definite (1+) erythema or tenderness-no UV exposure. 
Clinical response was judged independently by evaluating the pres-
ence and degree of scale, induration, and erythema. Therapeutic effect 
was then graded as follows: 
UV Source 
o = 0-25% clearance of lesions; 
1 + = 26-50% clearance of lesions; 
2+ = 51-75% clearance of lesions; 
3+ = 76-95% clearance of lesions; and 
4+ = greater than 95% clearance of lesions. 
All treatments were delivered in a walk-in cylindrical irradiation 
chamber approximately 2 meters in height and 1 meter in diameter. AU 
vertical surfaces were lined by a series of 74 vertically-arranged West-
inghouse FS40 and FS20 fluorescent sunlamps separated from each 
other by 1 cm. UVB spectral irradiance measurements were made using 
an International Light, Inc., Model 700 spectroradiometer. The irradi-
ance of wavelengths in the 280-315 nm band at a distance of 10 cm was 
880 J1. W Icm.~ The spectral power distribution of these lamps extends 
from 280 nm into the visible region with a broad peak at B13 nm. 
Erythemogenesis is due almost entirely to the UVB component (280-
315 nm) since wavelengths longer than 320 nm contribu te less than 1% 
of the erythemally effective energy of this sow-ceo Identical bulbs were 
used for all UVB MED determinations. 
For a ll UV A phototests, fluorescent bulbs identical to those used in 
oral psoralen photochemotherapy [14] were used. UV A spectral irra-
diance measurements were made using an International Light, Inc. , 
Model 441 radiometer which has a maximum response to 355 nm with 
a ha lf-bandwidth of 20 nm. During the cou rse of the study, the irradi-
ance was 7-10 mW/cm.~ 
RESULTS 
Group A (Table I) 
Compared to t he Eucerin-treated contralate ral side, none of 
the 3 tar preparations significan t ly affected t h e final grade of 
clearing of psoriasis on the 22nd day of hospitalization. At 
various times, one s ide or t h e other appeared to be clearing 
more rapidly; however, there was no consistent trend. At the 
end of the study, a detectable difference was observed in only 
3 patients (#3, #5, and #7), but even in these cases, both sides 
were in the same final assessment grade. In patients #3 and 
#5, t h e tar-treated side was marginally better, and in patient 
#7, the lubricant-treated s ide was better. In Group A, where 
regardless of response the study was concluded after 3 weeks, 
th e final grade was usually not as high as in Group B in which 
t h e study was often continued beyond 3 weeks to an endpoint 
of at least 95% clearance. 
Group B (Table II) 
Maximally aggressive UVB plus 5% CCT or lubricant pro-
duced essentially identical clearing of t h e psoriatic plaques. 
Five percent CCT plus UVB decreased the induration in t h e 
plaques of psoriasis more rapidly thao UVB plus white petro-
latum. However, when using total clearance as th e endpoint of 
evaluation we found that UVB plus white petrolatum was 
s imilar to UVB plus 5% CCT. Maximally aggressive UVB 
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TABLE 1. Group A: Final grading o( psoriasis a(ter 3 weells 
hospitalization 
5% Crude Coal 
Tar (CCT) 
5% Liquor Carbonis 
Detergens (LCD) 
Estal' 
Patient 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Grading (0-4+) 
5% CCT Eucerin 
4+ 4+ 
3+ 3+ 
3+ 3+ 
3+ 3+ 
4+ 4+ 
5% LCD Eucerin 
3+ 3+ 
3+ 3+ 
3+ 3+ 
4+ 4+ 
3+ 3+ 
Estar Eucerin 
3+ 3+ 
2+ 2+ 
2+ 2+ 
3+ 3+ 
4+ 4+ 
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Endpoint was clearance of one side or 21 days hospitalization which-
ever came rust. 
TABLE II. Group B: (inal grading o( psoriasis 3 days after total 
clearing o( one side 
White petrolatum 
vs no topical 
5% Crude Coal 
Tal' vs no 
topical 
5% Crude Coal 
Tal' vs White 
petrolatum 
Patient 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
No. treat-
ments 
to clear 
13 
15 
16 
19 
22 
13 
15 
16 
18 
10 
24 
18 
13 
25 
16 
(Grading 0 to +4) 
White No 
petrolatum topical 
4+ 2+ 
4+ 2+ 
4+ 2+ 
4+ 2+ 
4+ 1+ 
5% CCT No topical 
4+ 3+ 
4+ 1+ 
4+ 2+ 
4+ 2+ 
4+ 2+ 
5% CCT White petrolatum 
4+ 4+ 
4+ 4+ 
4+ 4+ 
4+ 4+ 
4+ 4+ 
Grading endpoint was clearance of psoriasis on one side plus 3 
additional days. 
without topical t herapy never completely cleared a ny patient 
(Figure). There was always a remarkable differen ce of at least 
one grade between t h e topically-treated side and t h e contralat-
eral (UVB only) side. 
The control patches frequently improved. Those control 
patches receiving topical t herapy without UV exposure had no 
scale and were usually less indurated than t hose control patches 
receiving neit h er topical agents nor UV exposure. At no t ime 
did t h e improvement in the control patches parallel t he im-
provement in t h e treated areas. 
The eryth ema response was essentially the same in all bilat-
eral comparisons of tar perparations a nd lubrican ts (Eucerin in 
Group A and white petrolatum in Group B). However, in 2 
cases in Group B t he 5% CeT side showed a darker coloration 
which was felt to represent staining of t h e stratum corneum. At 
som e time during the study, all patients h ad sufficient erythema 
to withhold UV therapy for at least on e treatment day. T h e 
erythema often was asymmetrical but t here was no predilection 
for eit her s ide. Nine patients had episodes of blistering. The 
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Patient #19. After 19 treatments, the right side, treated with white 
petrolatum and UV is clear and the left side treated with UV alone 
shows erythema, scale and induration typical of psoriasis vulgaris. 
vesicles and bullae were small, superficial, often grouped on a 
convex surface (e.g., shoulder) and involved both lesions (pso-
riatic) and nonlesional skin. A most unusual featUTe was that in 
2 of t he patients the skin surrounding the blisters was only 
minimally erythematous. The bullae evolved over 3 to 4 days 
before drying without scar formation. In 4 patients with tran-
sient ankle and/or pretibial edema, thorough investigation re-
vealed no cause other than UV exposure. After clearance one 
patient showed intense and persistent hyperpigmentation 
within the borders of the previous psoriatic lesion on the side 
treated with 5% CCT in whi te petrolatum. 
DISCUSSION 
During the past 53 yr, the combination of crude coal tar and 
ultraviolet light has become the standard of all therapies of 
psoriasis. Although recent work demonstrates that UV A (320-
400 nm) plus CCT causes interstrand cross-linking of DNA in 
guinea pig skin [15] and that UVA plus CCT depresses mitoses 
and DNA synthesis in hairless mice [16), Fisher and Maibach 
[17J found no suppression of DNA synthesis in normal human 
skin when CCT was irradiated with sunlight or UV A. Thus, 
neit her t he precise mechanism nor the necessary component(s) 
of this therapy has been fully elucidated. This becomes more 
confounding when one realizes that nearly every dermatologist 
has his own modification of t he Goeckerman regimen. 
Goeckerman [1] proposed that tar exerted its therapeutic 
effect by acting as a photosensitizer. This hypothesis would, at 
first glance, appear to be valid since the action spectrum of tar 
lies in the UV A region [18,19) and the spectral power distribu-
tion of hot quartz lamps is predominantly UV A and visible 
ligh t. However, even on the tar-treated skin ~rythemog~n~sis 
hom these sources is due almost entirely to their UVB emISSIon 
which, alt hough less t han the UV A emission, is more effective 
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in causing delayed eryth ema. It is possible that the interaction 
of UV A and tar triggers a cascade of events that evolve into a 
clinically evident therapeutic response, but our results do not 
support the supposition that tar photosensitization plays a role. 
To attain an erythemogenic dose of UV A from a m edium_ 
pressure mercury arc lamp would require very long exposure 
t imes (over 4 hr) that would simultaneously produce a severe 
erythemal reaction from the UVB emitted by this SOurce. The 
phototesting performed in our patients indic~ted that an MPD 
for 5% CCT is about 20 J of U VA. No patIent ever received 
more than 30% of his calculated MPD, and most received less 
than one-tenth this dose. 
Furthermore, in photo tests with FS40 fluorescent lamps, the 
addition of various tar preparations did not change the MED 
[19). Thus, it is unlikely that si?nifican~ erythema and cli.n~Cal 
response would result from the mteractlOn of a weak senSitiZer 
and the UV A emission from this source. 
During treatment, the clinical signs of pho~osensitization 
(erythema and blisters) were often asymmetrical; however, 
there was no preferential occurrence in the tar-treated areas. 
Consequently, we conclude that, ~n this study, the yl.r prepa-
rations did not enhance or potentiate the phototoxlclty of the 
UVB emitted from FS40 fluorescent lamps. 
At clearance (grade 4) there was no detectable difference in 
clinical response between the s ides of the body. receiving tal" 
and lubricant and lubricant alone. The mechanism by which 
the lubricant base aids the therapeutic effect of ult raviolet 
radiation is not known. These compounds may alter the ther-
apeutic response in vivo by altering th~ ~ptical propert.ies. of 
psoriatic skin . Increase in total tran.smlsslOn of UV radiatIOn 
has been demonstrated in normal skm tn vLtro With water and 
other polar substances [20). OpticH! effects o~ tOl?ic~ thera~e~­
tic agents have not been evaluated LIt vwo or LIt ULtro m psonatic 
skin . 
The presence of psoriasis plaques within o~ ~ontrol patch~s 
allowed us to determine whether a parabIOtIc or systemlC 
response, coincidental remission, or only topical application of 
tar or lubricant was sufficient to clear psoirasis. In no case did 
the psoriasis within the control patch ~ota?Y clear, a lthough 
those areas receiving only a tar preparatIOn lffiproved modestly 
and always more than those receiving n~ topical. the~apy ~r 
only a lubricating base. Thus, we agree With prevIOus mvestl-
gators [2,3,6,13,21] that tar has a defini te but modest therapeu-
tic effect on psoriasis. 
Ultraviolet radiation alone has been reported [3,8,9] to be 
effective in improving psoriasis. However, it appears that to be 
effective UV must be given in erythemogenic amounts. Previous 
studies in which UV has been considered ineffective [2,6,7] 
have not mentioned erythema response and it cannot be as-
sumed that the investigators maintained erythema throughout 
the study. In our study up to 4 weeks maximally aggressive UV 
exposw'e improved psoriasis, but ne.ver totally cleared psoriasis 
without the addition of some emollient. 
In studies where the investigators attempted to produce mild 
erythema [12,13,22], the combination of tar and UV was mo~e 
effective than was either element alone. In the present study ill 
which an attempt was made to maximize the UV exposure dose 
by carefully monitoring th~ er~thema response, t~r appeared to 
make no observable cont ributIOn to therapy. It IS conceivable 
that the benefi cial effect of tar becomes evident only when UV 
is administered in suberythemal doses. 
Therefore we conclude that maximally aggressive UV (290-
400 nm) the~apy in a hospitalized population will improve but 
not clear psoriasis. When combined with either 5% CCT, 5% 
LCD, Estar, Eucerin, or white petrolatum maximally aggressive 
UV leads to complete clearing of psoriasis. In combination with 
maximally aggressive UV, none of the 5 compounds offered any 
clear advantage over the others. 
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